Radiotherapy improves the outcomes of immunotherapy with Sintilimab in non-small-cell lung cancer: A real-world analysis.
Saved in:
| Title: | Radiotherapy improves the outcomes of immunotherapy with Sintilimab in non-small-cell lung cancer: A real-world analysis. |
|---|---|
| Authors: | Li S; Taizhou Hospital of Zhejiang Province, Shaoxing University, Taizhou, China.; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China., Chen K; Taizhou Hospital of Zhejiang Province, Shaoxing University, Taizhou, China.; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China., Yang M; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.; Indiana Academy for Science Mathematics and Humanities, Munci, IN, United States., Hlaing SS; Department of Internal Medicine, Crozer Chester Medical Center, Medical Center Blvd, Upland, PA, United States., Chen M; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China., Gu P; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China., Meng Y; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China., Yang H; Taizhou Hospital of Zhejiang Province, Shaoxing University, Taizhou, China.; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Sep 15; Vol. 13, pp. 991431. Date of Electronic Publication: 2022 Sep 15 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36189277 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Radiotherapy improves the outcomes of immunotherapy with Sintilimab in non-small-cell lung cancer: A real-world analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+S%22">Li S</searchLink>; Taizhou Hospital of Zhejiang Province, Shaoxing University, Taizhou, China.; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Taizhou Hospital of Zhejiang Province, Shaoxing University, Taizhou, China.; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.<br /><searchLink fieldCode="AU" term="%22Yang+M%22">Yang M</searchLink>; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.; Indiana Academy for Science Mathematics and Humanities, Munci, IN, United States.<br /><searchLink fieldCode="AU" term="%22Hlaing+SS%22">Hlaing SS</searchLink>; Department of Internal Medicine, Crozer Chester Medical Center, Medical Center Blvd, Upland, PA, United States.<br /><searchLink fieldCode="AU" term="%22Chen+M%22">Chen M</searchLink>; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.<br /><searchLink fieldCode="AU" term="%22Gu+P%22">Gu P</searchLink>; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.<br /><searchLink fieldCode="AU" term="%22Meng+Y%22">Meng Y</searchLink>; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.<br /><searchLink fieldCode="AU" term="%22Yang+H%22">Yang H</searchLink>; Taizhou Hospital of Zhejiang Province, Shaoxing University, Taizhou, China.; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Sep 15; Vol. 13, pp. 991431. <i>Date of Electronic Publication: </i>2022 Sep 15 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36189277 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2022.991431 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 991431 Titles: – TitleFull: Radiotherapy improves the outcomes of immunotherapy with Sintilimab in non-small-cell lung cancer: A real-world analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li S – PersonEntity: Name: NameFull: Chen K – PersonEntity: Name: NameFull: Yang M – PersonEntity: Name: NameFull: Hlaing SS – PersonEntity: Name: NameFull: Chen M – PersonEntity: Name: NameFull: Gu P – PersonEntity: Name: NameFull: Meng Y – PersonEntity: Name: NameFull: Yang H IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: 2022 Sep 15 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |